Home> Products> glidapaflozin 10 improved blood sugar levels

{ "products": [ { "_id": "665f0baed91d281c30c72ddb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 5/ 1000 ", "description": "GLIDAPAFLOZIN M 5/ 1000 \nDapagliflozin (5mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 5/1000 is a combination medication designed to provide balanced and effective control over Type 2 diabetes. It combines Dapagliflozin (5 mg) and Metformin (1000 mg), offering a synergistic approach to managing blood glucose levels and supporting overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (5 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a widely used medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 5/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides a balanced approach to blood glucose control and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 5/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 5/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 5/1000 offers a balanced and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-5-1000-133426", "price": 140.0, "discountamount": 42.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "dose", "meal", "Order", "EMAIL", "nausea", "kidneys", "1000 mg", "morning", "diarrhea", "improved", "concerns", "Patients", "increased", "Metformin", "one tablet", "Conclusion", "monitoring", "weight loss", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "long-term use", "single tablet", "Dapagliflozin", "CALL/WHATSAPP", "Type 2 diabetes", "dosing schedule", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "glycemic control", "multiple aspects", "balanced approach", "weight management", "effective control", "blood sugar levels", "several advantages", "Dosage adjustments", "genital infections", "diabetes management", "Common side effects", "personalized advice", "healthcare provider", "individual response", "insulin sensitivity", "synergistic approach", "glucose reabsorption", "metabolic parameters", "blood glucose control", "dual-action mechanism", "cardiovascular health", "Administration Dosage", "combination medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "lower blood glucose levels", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1318, "imageuri": "https://productimages.withfloats.com/actual/665f0bb10c19ea48b943ceaf.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0bb10c19ea48b943ceaf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:42:22.464Z", "updatedon": "2024-06-04T12:42:22.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-5-1000-/1318", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 5/ 1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f0a9787f0960e14a296d5", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/1000 ", "description": "GLIDAPAFLOZIN M 10/1000 \nDapagliflozin (10mg), Metformin (1000mg)\nIntroduction\nGLIDAPAFLOZIN M 10/1000 is a potent combination medication designed to effectively manage Type 2 diabetes. It combines Dapagliflozin (10 mg) and Metformin (1000 mg), providing a dual-action approach to blood glucose control and overall metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (1000 mg): Metformin is a cornerstone medication for Type 2 diabetes, improving insulin sensitivity, reducing liver glucose production, and decreasing intestinal glucose absorption. It helps lower blood sugar levels and may also support weight management.\nBenefits\nGLIDAPAFLOZIN M 10/1000 offers several advantages for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin at higher doses, it provides comprehensive control over blood glucose levels and metabolic parameters. This combination can lead to improved glycemic control, weight management, and cardiovascular health.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal to minimize gastrointestinal side effects. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/1000 should be taken in the morning to maximize its effectiveness throughout the day. It is important to adhere to the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/1000 may include urinary tract infections, genital infections, gastrointestinal disturbances (such as nausea or diarrhea), and potential vitamin B12 deficiency with long-term use. Patients should be aware of these potential side effects and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/1000 provides a comprehensive and effective treatment option for individuals with Type 2 diabetes, combining the benefits of Dapagliflozin and Metformin in a single tablet. Its dual-action mechanism targets multiple aspects of diabetes management, supporting improved glycemic control and metabolic health. Patients should consult their healthcare provider for personalized advice on dosage, monitoring, and management of potential side effects.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-1000-133425", "price": 205.0, "discountamount": 61.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "meal", "lower", "EMAIL", "Order", "nausea", "kidneys", "morning", "1000 mg", "diarrhea", "concerns", "improved", "Patients", "Metformin", "Conclusion", "monitoring", "one tablet", "weight loss", "information", "individuals", "higher doses", "Introduction", "sterisonline", "tolerability", "sterispharma", "effectiveness", "Dapagliflozin", "CALL/WHATSAPP", "long-term use", "single tablet", "SGLT2 inhibitor", "GLIDAPAFLOZIN M", "dosing schedule", "Type 2 diabetes", "multiple aspects", "glycemic control", "weight management", "genital infections", "blood sugar levels", "Dosage adjustments", "several advantages", "Common side effects", "healthcare provider", "insulin sensitivity", "personalized advice", "individual response", "diabetes management", "glucose reabsorption", "dual-action approach", "metabolic parameters", "blood glucose levels", "dual-action mechanism", "cardiovascular health", "comprehensive control", "Administration Dosage", "blood glucose control", "cornerstone medication", "potential side effects", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "liver glucose production", "urinary glucose excretion", "effective treatment option", "gastrointestinal side effects", "potent combination medication", "gastrointestinal disturbances", "intestinal glucose absorption", "potential vitamin B12 deficiency" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1317, "imageuri": "https://productimages.withfloats.com/actual/665f0a99c06ee12d88cb43d9.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f0a99c06ee12d88cb43d9.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:37:43.401Z", "updatedon": "2024-06-04T12:37:43.401Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-m-10-1000-/1317", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/1000 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6842b8014256f7114dfbd884", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TRELAQWK 100", "description": "Trelagliptin 100mg in TRELAQWK 100 is an innovative once-weekly oral medication formulated with Trelagliptin 100mg, specifically designed to support adults in managing type 2 diabetes mellitus (T2DM). As a member of the Dipeptidyl Peptidase-4 (DPP-4) inhibitor class, it provides a simplified and effective approach to improving glycemic control when combined with a healthy diet and regular exercise. Its weekly dosing schedule enhances treatment adherence, offering a more sustainable option for long-term diabetes care.\n\nActive Ingredient:\nTrelagliptin 100mg\nA potent, long-acting DPP-4 inhibitor that helps maintain stable blood glucose levels by preserving incretin activity. Incretins are natural hormones that promote insulin release and suppress glucagon, playing a vital role in blood sugar regulation.\n\nCore Benefits:\nConvenient once-weekly dosing enhances patient compliance\n\nEffectively lowers both fasting and postprandial (after-meal) blood sugar\n\nPromotes natural insulin production without contributing to weight gain\n\nCarries a low risk of hypoglycemia, especially when not used with insulin\n\nCan be used alone or in combination with other antidiabetic medications like metformin or sulfonylureas\n\nMechanism of Action:\nTRELAQWK 100 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These hormones play a crucial role in regulating blood sugar after meals. By prolonging their activity, Trelagliptin enhances insulin secretion and reduces glucagon levels, resulting in improved glycemic control. Its extended half-life allows for once-a-week administration, setting it apart from daily DPP-4 inhibitors.\n\nDosage & Administration:\nRecommended Dose: One tablet per week, or as advised by your doctor\n\nHow to Take: With or without food, preferably on the same day each week\n\nIf a dose is missed, do not double the next dose; seek guidance from your healthcare provider\n\nPossible Side Effects:\nTRELAQWK 100 is generally safe and well-tolerated. Some individuals may experience:\n\nHeadache\n\nNasopharyngitis (mild cold symptoms)\n\nConstipation\n\nUpper respiratory tract infections\n\nRare allergic reactions such as rashes or skin irritation\n\nSeek immediate medical advice if you experience unusual symptoms such as severe abdominal pain, persistent skin reactions, or signs of pancreatitis.", "price": 3.0, "discountamount": 1.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "medical advice", "generally safe", "healthcare provider", "food preferably", "extended halflife", "crucial role", "dpp4 enzyme", "sulfonylureas mechanism", "antidiabetic medications", "low risk", "vital role", "sustainable option", "regular exercise", "healthy diet", "effective approach", "support adults", "trelaqwk 100trelaqwk 100", "hormones play", "natural hormones", "dose seek guidance", "promote insulin release", "degrades incretin hormones", "experience unusual symptoms", "skin irritation seek", "onceaweek administration setting", "improved glycemic control", "regulating blood sugar", "weight gain carries", "suppress glucagon playing", "improving glycemic control" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2132, "imageuri": "https://productimages.withfloats.com/actual/6842b80c8a53ae8db15a02ac.png", "tileimageuri": "https://productimages.withfloats.com/tile/6842b80c8a53ae8db15a02ac.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-06-06T09:42:25.371Z", "updatedon": "2025-06-11T11:17:09.096Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2132", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Trelagliptin 100mg", "category": "DIABETIC RANGE", "tags": [ "Trelagliptin side effects", "Trelagliptin brand name", "Trelagliptin brands in India", "Trelagliptin uses", "Trelagliptin 100mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "67e152b7204f0ac1d74d3bb7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Empagliflozin 10 mg, Sitagliptin 100 mg", "description": "GLIEMPAFLOZIN SITA 10/100 is a powerful combination of Empagliflozin 10 mg and Sitagliptin 100 mg designed to effectively manage Type 2 Diabetes Mellitus. This dual-action formula helps regulate blood sugar levels, improves insulin sensitivity, and supports overall metabolic health. It is ideal for individuals who require an advanced approach to diabetes management while reducing the risk of complications.\n\n \nKey Benefits:\n \n\nEffective Blood Sugar Control – Helps maintain stable glucose levels throughout the day.\nDual-Action Formula – Targets blood sugar from different pathways for enhanced efficacy.\nWeight Management Support – Aids in mild weight loss by reducing excess glucose.\nCardiovascular Protection – May lower the risk of heart-related complications.\nReduces Risk of Hypoglycemia – Less likelihood of sudden blood sugar drops compared to some other diabetes medications.\n\n \nHow Does It Work?\n \n\nEmpagliflozin works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be eliminated through urine.\n\nSitagliptin increases insulin production while reducing the liver’s glucose output, leading to improved blood sugar control.\n\nTogether, these ingredients offer a comprehensive diabetes treatment approach, making it easier to maintain healthy glucose levels.\n\nDirections for Use:\n \n\nTake GLIEMPAFLOZIN SITA 10/100 as prescribed by your doctor.\n\nSwallow the tablet whole with a glass of water.\n\nCan be taken with or without food.\n\nMaintain a balanced diet and regular exercise for best results.\n\nDo not exceed the recommended dosage.\n\n \nSide Effects:\n \n\nWhile generally well-tolerated, some individuals may experience:\n\nIncreased Urination\nMild Nausea or Stomach Discomfort\nHeadache or Dizziness\nUrinary Tract Infections (UTIs)\nLow Blood Pressure (in some cases)\n\nSeek medical attention if you experience severe allergic reactions, dehydration, or persistent discomfort.", "price": 365.0, "discountamount": 110.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "generally welltolerated", "regular exercise", "balanced diet", "food maintain", "doctor swallow", "gliempaflozin sita 10100", "ingredients offer", "diabetes medications", "diabetes management", "advanced approach", "metabolic health", "powerful combination", "persistent discomfort", "empagliflozin 10mg", "stomach discomfort headache", "work empagliflozin works", "preventing glucose reabsorption", "mild weight loss", "sitagliptin 100mg designed" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2072, "imageuri": "https://productimages.withfloats.com/actual/67e152c98868d014155bafa6.png", "tileimageuri": "https://productimages.withfloats.com/tile/67e152c98868d014155bafa6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-03-24T12:40:23.819Z", "updatedon": "2025-03-27T12:58:36.708Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/empagliflozin-10-mg-sitagliptin-100-mg/2072", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIEMPAFLOZIN SITA 10/100", "category": "DIABETIC RANGE", "tags": [ "Empagliflozin and sitagliptin combination", "Empagliflozin and sitagliptin tablets", "Empagliflozin and sitagliptin combination brands", "Empagliflozin and sitagliptin tablets" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6662aa04db100e1fdc2dcb68", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VILDIABATE 100 ", "description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "GIP", "nose", "GLP-1", "EMAIL", "class", "meals", "Order", "timing", "throat", "enzyme", "Safety", "Dosage", "marker", "tobacco", "fasting", "response", "addition", "appetite", "headache", "patients", "Efficacy", "metformin", "Follow-Up", "adherence", "treatment", "VILDIABATE", "conclusion", "key points", "information", "monotherapy", "healthy diet", "instructions", "sterisonline", "pancreatitis", "inflammation", "sterispharma", "HbA1c levels", "CALL/WHATSAPP", "sulfonylureas", "crucial roles", "Administration", "insulin release", "nasopharyngitis", "kidney function", "glucagon levels", "gastric emptying", "specific aspects", "Clinical studies", "individual needs", "regular exercise", "other medications", "Vildagliptin acts", "incretin hormones", "DPP-4) inhibitors", "weight management", "insulin secretion", "glucose metabolism", "glucose regulation", "glucagon secretion", "blood sugar levels", "Regular monitoring", "Combination Therapy", "glycemic parameters", "common side effects", "Blood Sugar Control", "medical supervision", "healthcare provider", "essential components", "synergistic benefits", "different mechanisms", "Serious side effects", "pancreatic beta cells", "dipeptidyl peptidase-4", "oral antidiabetic agent", "Lifestyle Modifications", "glucose-dependent manner", "excessive alcohol intake", "overall glycemic control", "type 2 diabetes mellitus", "lifestyle recommendations", "other relevant parameters", "long-term glucose control", "hypersensitivity reactions", "postprandial hyperglycemia", "optimal diabetes management", "postprandial glucose levels", "postprandial glucose control", "other antidiabetic medications", "upper respiratory tract infections", "effective oral antidiabetic medication", "glucose-dependent insulinotropic peptide" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1491, "imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-07T06:34:44.056Z", "updatedon": "2024-06-28T11:58:50.164Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VILDIABATE 100 ", "category": "DIABETIC RANGE", "tags": [ "VILDIABATE 100", "Vildagliptin (100mg)", "Vildagliptin 100 mg uses", "Vildagliptin 100 mg price", "Vildagliptin 100 mg SR brand Name", "Vildagliptin 100 mg brands in India", "", "Vildagliptin 100 mg generic medicine", "Vildagliptin 100 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66604813db9fdd21801edf75", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 1000 ", "description": "IMEGLIMON 1000 \nImeglimin Hydrochloride 1000 mg\nIntroduction to IMEGLIMON 1000\nIMEGLIMON 1000 contains Imeglimin Hydrochloride 1000mg, a novel oral medication used for the management of type 2 diabetes mellitus. Imeglimin represents a new class of oral antidiabetic agents known as \"glimins,\" which have a unique mechanism of action that targets multiple pathways involved in glucose metabolism. This medication helps improve blood sugar control by enhancing insulin sensitivity, increasing insulin secretion, and improving mitochondrial function.\n\nWhat is Imeglimin?\nOverview of Imeglimin\nImeglimin is a new oral antidiabetic agent that works through a multifaceted mechanism to improve glycemic control in patients with type 2 diabetes. Unlike traditional antidiabetic medications, Imeglimin targets multiple defects associated with type 2 diabetes, providing a comprehensive approach to managing blood sugar levels.\n\nMechanism of Action\nInsulin Sensitization: Imeglimin enhances insulin sensitivity in muscle and liver tissues, leading to improved glucose uptake and utilization.\nInsulin Secretion: It increases insulin secretion in response to glucose, helping to maintain more stable blood sugar levels.\nMitochondrial Function: Imeglimin improves mitochondrial function, which helps to reduce oxidative stress and improve overall cellular energy metabolism.\nBenefits of IMEGLIMON 1000\nEffective Blood Sugar Management\nPostprandial and Fasting Glucose Control: IMEGLIMON 1000 helps regulate both postprandial (after-meal) and fasting blood glucose levels by improving insulin sensitivity and secretion.\nComprehensive Glycemic Control: The unique mechanism of action of Imeglimin addresses multiple pathways involved in glucose metabolism, providing comprehensive blood sugar management.\nSupport for Diabetes Management\nDiet and Exercise Adjunct: IMEGLIMON 1000 is an excellent adjunct to diet and exercise, helping patients achieve better blood sugar control when lifestyle modifications alone are insufficient.\nReduced Risk of Complications: By maintaining more stable blood sugar levels, IMEGLIMON 1000 can help reduce the risk of long-term complications associated with diabetes, such as cardiovascular disease, neuropathy, and retinopathy.\nAdditional Health Benefits\nImproved Mitochondrial Function: The positive effects on mitochondrial function can lead to reduced oxidative stress and improved overall cellular health.\nWeight Management: Imeglimin has a neutral effect on body weight, making it a suitable option for patients concerned about weight gain associated with some antidiabetic medications.\nHow to Use IMEGLIMON 1000\nDosage and Administration\nRecommended Dosage: The typical dosage of IMEGLIMON 1000 is one tablet taken twice daily, with meals. Your healthcare provider may adjust the dosage based on your individual response and blood sugar levels.\nAdministration: Take the tablet with meals to enhance absorption and reduce the risk of gastrointestinal discomfort. Swallow the tablet whole with a full glass of water.\nGuidelines for Optimal Use\nConsistent Use: For best results, take IMEGLIMON 1000 regularly as prescribed by your healthcare provider.\nMonitor Blood Sugar Levels: Regularly check your blood sugar levels to ensure the medication is effectively controlling your diabetes. Adjustments to your treatment plan may be necessary based on these readings.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/imeglimon-1000-134380", "price": 249.0, "discountamount": 74.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "meal", "Diet", "EMAIL", "Order", "water", "muscle", "action", "option", "glimins", "Support", "Overview", "readings", "patients", "new class", "absorption", "Guidelines", "full glass", "neuropathy", "one tablet", "Optimal Use", "body weight", "weight gain", "retinopathy", "Adjustments", "information", "utilization", "Postprandial", "Introduction", "Reduced Risk", "sterispharma", "best results", "sterisonline", "CALL/WHATSAPP", "liver tissues", "neutral effect", "Administration", "glucose uptake", "Consistent Use", "typical dosage", "treatment plan", "IMEGLIMON 1000", "positive effects", "Exercise Adjunct", "multiple defects", "unique mechanism", "oxidative stress", "excellent adjunct", "multiple pathways", "Weight Management", "insulin secretion", "Recommended Dosage", "glucose metabolism", "Diabetes Management", "blood sugar control", "insulin sensitivity", "individual response", "healthcare provider", "blood glucose levels", "Insulin Sensitization", "novel oral medication", "multifaceted mechanism", "comprehensive approach", "cardiovascular disease", "mitochondrial function", "Imeglimin Hydrochloride", "long-term complications", "lifestyle modifications", "Fasting Glucose Control", "overall cellular health", "type 2 diabetes mellitus", "oral antidiabetic agents", "stable blood sugar levels", "Additional Health Benefits", "new oral antidiabetic agent", "gastrointestinal discomfort", "Comprehensive Glycemic Control", "Effective Blood Sugar Management", "overall cellular energy metabolism", "comprehensive blood sugar management", "traditional antidiabetic medications" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1374, "imageuri": "https://productimages.withfloats.com/actual/666048160c19ea48b94647a6.png", "tileimageuri": "https://productimages.withfloats.com/tile/666048160c19ea48b94647a6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-05T11:12:19.246Z", "updatedon": "2024-06-29T12:04:08.061Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imeglimon-1000-/1374", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "IMEGLIMON 1000 ", "category": "DIABETIC RANGE", "tags": [ "IMEGLIMON 1000", "Imeglimin Hydrochloride 1000 mg", "Imeglimin hydrochloride 1000 mg uses", "Imeglimin 1000 Uses in Hindi", "Imeglimin 1000 side effects", "Imeglyn 1000 composition", "Imeglyn 1000 generic name" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f09d8db9fdd21801ec775", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN M 10/500 ", "description": "GLIDAPAFLOZIN M 10/500 \nDapagliflozin (10mg), Metformin (500mg) SR\nIntroduction\nGLIDAPAFLOZIN M 10/500 combines two potent medications, Dapagliflozin (10 mg) and Metformin (500 mg, sustained-release), into a single tablet. This formulation offers a comprehensive approach to managing Type 2 diabetes by targeting both blood glucose levels and metabolic health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin is an SGLT2 inhibitor that works in the kidneys to reduce glucose reabsorption, leading to increased urinary glucose excretion. This action helps lower blood glucose levels and can also promote weight loss and cardiovascular benefits.\nMetformin (500 mg, sustained-release): Metformin is a widely used medication that improves insulin sensitivity, reduces glucose production in the liver, and decreases intestinal glucose absorption. The sustained-release formulation ensures a gradual release of Metformin, minimizing gastrointestinal side effects.\nBenefits\nGLIDAPAFLOZIN M 10/500 offers several benefits for individuals with Type 2 diabetes. By combining Dapagliflozin and Metformin, it provides dual-action control over blood glucose levels, enhances insulin sensitivity, and supports overall metabolic health. This combination can lead to improved glycemic control and may also assist in weight management.\n\nDosage and Administration\n\nDosage: The recommended dose is one tablet per day, taken with a meal. Dosage adjustments may be necessary based on individual response and tolerability.\nAdministration: GLIDAPAFLOZIN M 10/500 should be taken in the morning to maximize its effectiveness throughout the day. It is important to follow the prescribed dosing schedule consistently.\nSide Effects\nCommon side effects of GLIDAPAFLOZIN M 10/500 may include urinary tract infections, genital infections, and gastrointestinal disturbances such as nausea or diarrhea. These side effects are generally mild and transient, but patients should be aware of them and report any concerns to their healthcare provider.\n\nConclusion\nGLIDAPAFLOZIN M 10/500 is a convenient and effective option for individuals with Type 2 diabetes, offering dual-action control over blood glucose levels and metabolic health. Its combination of Dapagliflozin and Metformin provides a comprehensive approach to diabetes management, potentially leading to improved outcomes and better quality of life. Patients should consult their healthcare provider for personalized advice on dosage and monitoring.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-m-10-500-133423", "price": 275.0, "discountamount": 82.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SR", "day", "meal", "dose", "life", "liver", "Order", "EMAIL", "lower", "better", "500 mg", "nausea", "quality", "kidneys", "morning", "diarrhea", "concerns", "patients", "Metformin", "Mechanism", "increased", "Conclusion", "one tablet", "convenient", "monitoring", "weight loss", "combination", "information", "individuals", "Introduction", "sterisonline", "tolerability", "sterispharma", "Dapagliflozin", "single tablet", "CALL/WHATSAPP", "effectiveness", "GLIDAPAFLOZIN M", "dosing schedule", "gradual release", "SGLT2 inhibitor", "Type 2 diabetes", "several benefits", "effective option", "glycemic control", "weight management", "improved outcomes", "Dosage adjustments", "genital infections", "glucose production", "personalized advice", "diabetes management", "healthcare provider", "individual response", "dual-action control", "insulin sensitivity", "Common side effects", "blood glucose levels", "glucose reabsorption", "Administration Dosage", "two potent medications", "comprehensive approach", "cardiovascular benefits", "overall metabolic health", "urinary tract infections", "urinary glucose excretion", "gastrointestinal side effects", "intestinal glucose absorption", "gastrointestinal disturbances", "sustained-release formulation" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1315, "imageuri": "https://productimages.withfloats.com/actual/665f09da137212f68f05951a.png", "tileimageuri": "https://productimages.withfloats.com/tile/665f09da137212f68f05951a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:34:32.323Z", "updatedon": "2024-06-04T12:34:32.323Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//glidapaflozin-m-10-500-/1315", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN M 10/500 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "665f081d8da3a81d5c69e8ec", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "GLIDAPAFLOZIN 10 ", "description": "GLIDAPAFLOZIN 10 \nDapagliflozin (10mg)\nIntroduction\nGLIDAPAFLOZIN 10 is a highly effective medication formulated specifically for the treatment of Type 2 diabetes. This oral tablet contains 10 mg of Dapagliflozin, an SGLT2 inhibitor that plays a crucial role in managing blood glucose levels and supporting overall cardiovascular health.\n\nMechanism of Action\n\nDapagliflozin (10 mg): Dapagliflozin operates by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the kidneys. This inhibition prevents the reabsorption of glucose back into the bloodstream, promoting the excretion of glucose through urine. This process not only helps lower blood sugar levels but also aids in calorie reduction and weight management.\nBenefits\nGLIDAPAFLOZIN 10 is particularly beneficial for patients looking to control their blood sugar levels effectively while also addressing other metabolic aspects like weight and blood pressure. It has been associated with cardiovascular benefits, making it a preferred choice for diabetic patients with heart-related concerns.\n\nDosage and Administration\n\nDosage: The recommended starting dose is one 10 mg tablet per day. Dosage adjustments should be based on individual efficacy and tolerability, under the guidance of a healthcare professional.\nAdministration: GLIDAPAFLOZIN 10 should be taken in the morning, with or without food. Consistency in taking the medication at the same time each day is important for maintaining stable glucose levels.\nSide Effects\nThe most common side effects of GLIDAPAFLOZIN 10 include genital and urinary tract infections due to the increased glucose in the urine. Patients may also experience signs of dehydration and low blood pressure. It is important for users to stay well-hydrated and monitor for signs of excessive urination and thirst.\n\nConclusion\nGLIDAPAFLOZIN 10 offers an effective, focused approach to managing Type 2 diabetes through its unique action on renal glucose processing. It simplifies diabetes management by providing a once-daily oral treatment that supports blood sugar control while potentially improving cardiovascular and metabolic health. As with any medication, it is crucial to consult a healthcare provider to tailor the treatment to individual needs and circumstances.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/glidapaflozin-10-133427\n\n\n\n\n\n", "price": 240.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "Order", "signs", "users", "EMAIL", "urine", "thirst", "choice", "kidneys", "genital", "morning", "guidance", "same time", "Mechanism", "excretion", "Conclusion", "inhibition", "Consistency", "oral tablet", "dehydration", "information", "bloodstream", "Introduction", "reabsorption", "crucial role", "sterispharma", "tolerability", "sterisonline", "GLIDAPAFLOZIN", "circumstances", "CALL/WHATSAPP", "Dapagliflozin", "unique action", "starting dose", "oral treatment", "Type 2 diabetes", "SGLT2 inhibitor", "one 10 mg tablet", "metabolic health", "individual needs", "weight management", "diabetic patients", "calorie reduction", "blood sugar levels", "Dosage adjustments", "low blood pressure", "individual efficacy", "common side effects", "excessive urination", "diabetes management", "healthcare provider", "blood sugar control", "effective medication", "blood glucose levels", "stable glucose levels", "Administration Dosage", "heart-related concerns", "cardiovascular benefits", "healthcare professional", "other metabolic aspects", "urinary tract infections", "renal glucose processing", "effective, focused approach", "sodium-glucose cotransporter", "overall cardiovascular health" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1310, "imageuri": "https://productimages.withfloats.com/actual/665f0820c40ee9be019637c3.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/665f0820c40ee9be019637c3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-04T12:27:09.955Z", "updatedon": "2024-06-04T12:27:09.955Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glidapaflozin-10-/1310", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIDAPAFLOZIN 10 ", "category": "DIABETIC RANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662f6c3225c2821e38859efe", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "IMEGLIMON 1000 ", "description": "IMEGLIMON 1000 \nImeglimin Hydrochloride 1000 mg\n\nImeglimon 1000 is a medication containing Imeglimin Hydrochloride 1000 mg. It is used in the management of type 2 diabetes mellitus to help control blood sugar levels. Imeglimon works by targeting multiple pathways involved in glucose metabolism, leading to improved insulin sensitivity and reduced glucose production by the liver. This medication is typically taken orally, usually once or twice daily, as directed by a healthcare professional. Common side effects may include nausea, diarrhea, headache, and hypoglycemia. It's important to follow your doctor's instructions and monitor your blood sugar levels regularly while using Imeglimon 1000.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n", "price": 249.0, "discountamount": 75.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "liver", "nausea", "doctor", "headache", "diarrhea", "IMEGLIMON", "management", "medication", "hypoglycemia", "instructions", "multiple pathways", "glucose production", "glucose metabolism", "blood sugar levels", "insulin sensitivity", "Common side effects", "healthcare professional", "type 2 diabetes mellitus", "Imeglimin Hydrochloride 1000 mg" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 813, "imageuri": "https://productimages.withfloats.com/actual/662f6c35ee06449a3f593c8b.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/662f6c35ee06449a3f593c8b.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-29T09:45:22.944Z", "updatedon": "2024-06-12T12:56:16.672Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/imeglimon-1000-/813", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Imeglimin Hydrochloride 1000 mg", "category": "NEUROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }